CASP8 and metabolic dysfunction-associated steatohepatitis: Therefore, hepatocyte Caspase-8 is critical for the pathogenesis of steatohepatitis, drugs targeting Caspase-8 might be a plausible treatment for NAFLD/NASH [39].